Quite paradoxically, ApoE polymorphism in young healthy carriers (i.e., subjects who have therefore a higher risk of developing AD later on in life) have the tendency to perform decision-making and prospective memory tasks better than, ApoE3 carriers (who are instead protected, by virtue of this genotype, from AD; Marchant et al., 2010). Here, APOE is linked to Alzheimer disease.